A lab technician shows the coronavirus treatment drug remdesivir at Eva Pharma Facility in Cairo, Egypt. Photo: Reuters A lab technician shows the coronavirus treatment drug remdesivir at Eva Pharma Facility in Cairo, Egypt. Photo: Reuters
A lab technician shows the coronavirus treatment drug remdesivir at Eva Pharma Facility in Cairo, Egypt. Photo: Reuters

Gilead questions WHO study that found remdesivir has little effect on Covid-19 deaths

  • The UN health agency said its ‘Solidarity’ trial conducted in 11,266 patients had concluded that remdesivir did little to help patients survive
  • The US company said the the findings were premature and that other studies had validated the drug’s benefits

Topic |   Coronavirus pandemic
A lab technician shows the coronavirus treatment drug remdesivir at Eva Pharma Facility in Cairo, Egypt. Photo: Reuters A lab technician shows the coronavirus treatment drug remdesivir at Eva Pharma Facility in Cairo, Egypt. Photo: Reuters
A lab technician shows the coronavirus treatment drug remdesivir at Eva Pharma Facility in Cairo, Egypt. Photo: Reuters
READ FULL ARTICLE